October 27, 2017

FDA Has Approved MDMA Trials for PTSD Treatment

October 27, 2017
foliage-1157792_1920
The American Psychiatric Association published an article last week that said researchers have already done 16 years of trials on MDMA and have come to believe that it could be a breakthrough therapy for people suffering from severe PTSD.

FDA Has Approved MDMA Trials for PTSD Treatment

The Food and Drug Administration (FDA) approved several phase-3 trials of 3, 4-methylenedioxymethamphetamine (MDMA), otherwise known as ecstasy, for Post-Traumatic Stress Disorder. Researchers believe the drug could be the best new treatment for the disorder.

The American Psychiatric Association published an article last week that said researchers have already done 16 years of trials on the drug and have come to believe that it could be a breakthrough therapy for people suffering from severe PTSD.

The founder of the Multidisciplinary Association for Psychedelic Studies (MAPS) Rick Doblin said that “For the first time ever, psychedelic-assisted psychotherapy will be evaluated in Phase 3 trials for possible prescription use, with MDMA-assisted psychotherapy for PTSD leading the way. Now that we have agreement with FDA, we are ready to start negotiations with the European Medicines Agency.”

At least 868,000 of our military veterans are on disability for PTSD, costing the Department of Veterans Affairs $17 billion annually. If the treatment truly is a breakthrough drug, many of those veterans may be able to return to work if the drug is legalized and regulated.

MDMA became famous by its nickname ecstasy as a club drug at rave parties. It is best known for its euphoric feel-good touchy qualities. While the drug can make you feel fantastic, it can also be dangerous. The amphetamine in MDMA drug can elevate the heartrate and blood pressure or cause overheating and dehydration. It can also have negative psychological effects and induce extreme emotions. Enough deaths occurred from the club drug that the DEA classified in the same class with heroin in 1985.

The trials will consist of patients with severe PTSD in Canada, Israel and the U.S. starting in the spring of next year.

Niko Mann is a freelance writer living in Los Angeles.

Share:

Share on facebook
Facebook
Share on twitter
Twitter
Share on pinterest
Pinterest
Share on reddit
Reddit
Recent & Related Posts

Articles

Recent & Related Posts
Medical
Mark Willey

Missouri Green Doctors

Since voters passed Amendment 2 with an overwhelming majority in 2018, Missouri has become a new medical marijuana landscape and has seen approximately 50,000 patients

Read More »
Medical
Ryan Quinones

Hemp Missouri

Missourians have been growing hemp as a staple crop dating back to the early-nineteenth century. American farmers grew hemp all over the country and manufactured

Read More »
Missouri Sneate Bill 491 took decriminalization one step further in the Show-Me-State.
Medical
Brodie Kush

Missouri Senate Bill 491

Missouri is now a legal medical marijuana state, but six years ago in 2014, the Missouri legislature was able to pass SB 491 a modified,

Read More »
Medical
Ryan Quinones

Missouri Marijuana Laws

Over the past couple years, Missouri has been rapidly amping up its efforts to overturn drug war era policies and replace them with a regulated 

Read More »
Medical
John Payne

Missouri Marijuana Legalization

11 states have legalized recreational marijuana, and another 22 states, plus the District of Columbia, have legalized medical cannabis. So,  here’s where things stand here

Read More »